A randomized open-label trial of artesunate- sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan

Badria El-Sayed, Salah-Eldin El-Zaki, Hamza Babiker, Nahla Gadalla, Tellal Ageep, Fathi Mansour, Omer Baraka, Paul Milligan, Ahmed Babiker, Badria El-Sayed, Salah-Eldin El-Zaki, Hamza Babiker, Nahla Gadalla, Tellal Ageep, Fathi Mansour, Omer Baraka, Paul Milligan, Ahmed Babiker

Abstract

Background: In areas of seasonal malaria transmission, treatment of asymptomatic carriers of malaria parasites, whose parasitaemia persists at low densities throughout the dry season, could be a useful strategy for malaria control. We carried out a randomized trial to compare two drug regimens for clearance of parasitaemia in order to identify the optimum regimen for use in mass drug administration in the dry season.

Methodology and principal findings: A two-arm open-label randomized controlled trial was conducted during the dry season in an area of distinct seasonal malaria in two villages in Gedarif State in eastern Sudan. Participants were asymptomatic adults and children aged over 6 months, with low-density P. falciparum infection detected by PCR. Participants were randomized to receive artesunate/sulfadoxine-pyrimethamine (AS+SP) combination for three days with or without a dose of primaquine (PQ) on the fourth day. Parasitaemia detected by PCR on days 3, 7 and 14 after the start of treatment and gametocytes detected by RT-PCR on days 7 and 14 were then recorded. 104 individuals who had low density parasitaemia at screening were randomized and treated during the dry season. On day 7, 8.3% were positive by PCR in the AS+SP+PQ group and 6.5% in the AS+SP group (risk difference 1.8%, 95%CI -10.3% to +13.8%). At enrolment, 12% (12/100) were carrying gametocytes. This was reduced to 6.4% and 4.4% by day 14 (Risk difference 1.9% (95%CI -9.3% to +13.2%) in AS+SP+PQ and AS+SP groups, respectively.

Conclusion: Addition of primaquine to artemisinin combination treatment did not improve elimination of parasitaemia and prevention of gametocyte carriage in carriers with low-density parasitaemia in the dry season.

Trial registration: ClinicalTrials.gov NCT00330902.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. CONSORT Flowchart
Figure 1. CONSORT Flowchart

References

    1. Roper C, Elhassan IM, Hviid L, Giha H, Richardson W, et al. Detection of Very Low Level Plasmodium falciparum Infections using the Nested Polymerase Chain Reaction and a Reassessment of the Epidemiology of Unstable Malaria in Sudan. Am J Trop Med Hyg. 1996;54:325–331.
    1. Babiker HA, Abdel-Muhsin AM, Ranford-Cartwright LC, Satti G, Walliker D. Characteristics of Plasmodium falciparum parasites that survive the lengthy dry season in eastern Sudan where malaria transmission is markedly seasonal. Am J Trop Med Hyg. 1998;59:582–590.
    1. Babiker HA, Abdel-Muhsin AA, Hamad A, Mackinnon MJ, Hill WG, et al. Population dynamics of Plasmodium falciparum in an unstable malaria area of eastern Sudan. Parasitology. 2000;120(Pt 2):105–111.
    1. Babiker HA, Abdel-Wahab A, Ahmed S, Suleiman S, Ranford-Cartwright L, et al. Detection of low level Plasmodium falciparum gametocytes using reverse transcriptase polymerase chain reaction. Mol Biochem Parasitol. 1999;99:143–148.
    1. Menegon M, Severini C, Sannella A, Paglia MG, Sangare D, et al. Genotyping of Plasmodium falciparum gametocytes by reverse transcriptase polymerase chain reaction. Mol Biochem Parasitol. 2000;111:153–161.
    1. Abdel-Wahab A, Abdel-Muhsin AM, Ali E, Suleiman S, Ahmed S, et al. Dynamics of gametocytes among Plasmodium falciparum clones in natural infections in an area of highly seasonal transmission. J Infect Dis. 2002;185:1838–1842.
    1. Nassir E, Abdel-Muhsin AM, Suliaman S, Kenyon F, Kheir A, et al. Impact of genetic complexity on longevity and gametocytogenesis of Plasmodium falciparum during the dry and transmission-free season of eastern Sudan. Int J Parasitol. 2005;35:49–55.
    1. Talman AM, Domarle O, McKenzie FE, Ariey F, Robert V. Gametocytogenesis: the puberty of Plasmodium falciparum. Malar J. 2004;3:24.
    1. Eichner M, Diebner HH, Molineaux L, Collins WE, Jeffery GM, et al. Genesis, sequestration and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a model to malariatherapy data. Trans R Soc Trop Med Hyg. 2001;95:497–501.
    1. Suputtamongkol Y, Chindarat S, Silpasakorn S, Chaikachonpatd S, Lim K, et al. The efficacy of combined mefloquine-artesunate versus mefloquine-primaquine on subsequent development of Plasmodium falciparum gametocytemia. Am J Trop Med Hyg. 2003;68:620–623.
    1. Dunyo S, Milligan P, Edwards T, Sutherland C, Targett G, et al. Gametocytaemia after drug treatment of asymptomatic Plasmodium falciparum. PLoS Clin Trials. 2006;1:e20.
    1. Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, et al. Artesunate combinations for treatment of malaria: meta-analysis. Lancet. 2004;363:9–17.
    1. Pukrittayakamee S, Chotivanich K, Chantra A, Clemens R, Looareesuwan S, et al. Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria. Antimicrob Agents Chemother. 2004;48:1329–1334.
    1. Bunnag D, Harinasuta T, Pinichpongse S, Suntharasami P. Effect of primaquine on gametocytes of Plasmodium falciparum in Thailand. Lancet. 1980;2:91.
    1. Grewal RS. Pharmacology of 8-aminoquinolines. Bull World Health Organ. 1981;59:397–406.
    1. WHO. Antimalarial drug policies: data requirements, treatment of uncomplicated malaria and management of malaria in pregnancy. Geneva: (unpublished document WHO/MAL/94.1070; available on request from the Documentation Centre, Communicable Diseases, World Health Organization, 1211 Geneva 27, Switzerland); 1994.
    1. Muirhead-Thomson RC. Factors determining the true reservoir of infection of Plasmodium falciparum and Wuchereria bancrofti in a West African village. Trans R Soc Trop Med Hyg. 1954;48:208–225.
    1. Carter R, G, RW . In: Infectiousness and gamete immunization malaria. J K, editor. New York: Academic Press, Inc; 1980. pp. 263–298.
    1. Hamad AA, Nugud Ael H, Arnot DE, Giha HA, Abdel-Muhsin AM, et al. A marked seasonality of malaria transmission in two rural sites in eastern Sudan. Acta Trop. 2002;83:71–82.
    1. Bayoumi RA, Babiker HA, Ibrahim SM, Ghalib HW, Saeed BO, et al. Chloroquine-resistant Plasmodium falciparum in eastern Sudan. Acta Trop. 1989;46:157–165.
    1. Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg. 1995;52:565–568.
    1. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol. 1993;58:283–292.
    1. von Seidlein L, Milligan P, Pinder M, Bojang K, Anyalebechi C, et al. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet. 2000;355:352–357.
    1. Newcombe RG. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med. 1998;17:873–890.
    1. Kitchen SF, P P. Observations on the mechanism of the parasite cycle in falciparum malaria. Am J Trop Med. 1942;22:381–386.
    1. Dearsly AL, Sinden RE, Self IA. Sexual development in malarial parasites: gametocyte production, fertility and infectivity to the mosquito vector. Parasitology. 1990;100(Pt 3):359–368.
    1. Carter R, Graves P. Gametocytes. In: McGregor WHWaIS, editor. Malaria: Principles and Practice of Malariology. Edinburgh: Churchill Livingstone; 1989. pp. 1–59.
    1. Dyer M, Day KP. Regulation of the rate of asexual growth and commitment to sexual development by diffusible factors from in vitro cultures of Plasmodium falciparum. Am J Trop Med Hyg. 2003;68:403–409.
    1. Taylor LH, Read AF. Why so few transmission stages? Reproductive restraint by malaria parasites. Parasitol Today. 1997;13:135–140.
    1. Robert V, Molez JF, Trape JF. Short report: gametocytes, chloroquine pressure, and the relative parasite survival advantage of resistant strains of falciparum malaria in west Africa. Am J Trop Med Hyg. 1996;55:350–351.
    1. Graves PM, Carter R, McNeill KM. Gametocyte production in cloned lines of Plasmodium falciparum. Am J Trop Med Hyg. 1984:1045–1050.
    1. Sattabongkot J, Maneechai N, Rosenberg R. Plasmodium vivax: gametocyte infectivity of naturally infected Thai adults. Parasitology. 1991;102(Pt 1):27–31.
    1. Dowling MA, Shute GT. A comparative study of thick and thin blood films in the diagnosis of scanty malaria parasitaemia. Bull World Health Organ. 1966;34:249–267.
    1. Sauerwein RW, Eling WM. Sexual and sporogonic stage antigens. Chem Immunol. 2002;80:188–203.
    1. Schneider P, Bousema JT, Gouagna LC, Otieno S, van de Vegte-Bolmer M, et al. Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Am J Trop Med Hyg. 2007;76:470–474.
    1. Kaslow DC, Quakyi IA, Keister DB. Minimal variation in a vaccine candidate from the sexual stage of Plasmodium falciparum. Mol Biochem Parasitol. 1989;32:101–103.
    1. Carter R, Gwadz RW. Research in Malaria. New York: Academic Press, Inc; 1980. Infectiousness and gamete immunization malaria. pp. 263–298. In: J K, editor.
    1. Targett G, Drakeley C, Jawara M, von Seidlein L, Coleman R, et al. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J Infect Dis. 2001;183:1254–1259.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit